Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00279305

Locations


United States, California
	Childrens Hospital of Los Angeles
	Los Angeles, California, United States, 90027
	Stanford University
	Stanford, California, United States, 94305
	University of California-San Francisco
	San Francisco, California, United States, 94143

United States, Colorado
	Barbara Davis Center for Childhood Diabetes
	Aurora, Colorado, United States, 80010

United States, Florida
	University of Florida
	Gainesville, Florida, United States, 32610-0296
	University of Miami
	Miami, Florida, United States, 33136

United States, Indiana
	Indiana University-Riley Hospital for Children
	Indianapolis, Indiana, United States, 46202

United States, Massachusetts
	Joslin
	Boston, Massachusetts, United States, 02215

United States, Minnesota
	University of Minnesota
	Minneapolis, Minnesota, United States, 55455

United States, New York
	Columbia University
	New York, New York, United States, 10032
	Columbia University
	New York, New York, United States, 10032

United States, Pennsylvania
	University of Pittsburgh
	Pittsburgh, Pennsylvania, United States, 15213

United States, Texas
	University of Texas
	Dallas, Texas, United States, 75235-8858

United States, Washington
	Benaroya Research Institute
	Seattle, Washington, United States, 98101

Australia
	Walter and Eliza Hall Institute of Medical Research
	Victoria, Australia

Canada, Ontario
	The Hospital for Sick Children
	Toronto, Ontario, Canada, M5G 1X8

Italy
	San Raffaele Hospital
	Milan, Italy

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

American Diabetes Association

Juvenile Diabetes Research Foundation

Investigators


Principal Investigator:	Mark Pescovitz, MD	Type 1 Diabetes TrialNet